Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2013-11-14
Original SEC Filing: Click here

---

Webplus: BSPM/20131114/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
Biostar Pharmaceuticals, Regainsmpliance With NASDAQ $1.00 Minimum Bid Price Rule BSPM XIANYANG, China, Nov. 13, 2013 /PRNewswire/ — Biostar Pharmaceuticals, ( Ronghua Wang, Biostar’s Chairman,mmenting on the announcement, stated: “We strongly believe that regainingmpliance with NASDAQ’sntinued listing requirements is an important achievement for thempany. Having resolved this issue, wenntinue focusing on maximizing shareholder value and

---

---

Webplus: BSPM/20131114/8-K/1/000.htm SEC Original: biostarpharma8k111313.htm
FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported):November 11, 2013 BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last report)

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2013-11-14CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046